March 28, 2020

Structural Heart Devices Market will be growing at a CAGR of 10.7% during the forecast period from 2018 to 2026

The latest market report published by Credence Research, Inc. “Structural Heart Devices Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global market for structural heart devices was valued at US$ 7.5 billion in 2017 and is expected to reach US$ 18.9 billion by 2026, increasing to CAGR by 10.7 per cent from 2018 to 2026.

Market Insights

Structural heart disease is a non-coronary abnormality that includes conditions that are either congenital or due to certain abnormalities in the heart valves and vessels due to age or underlying conditions. Common conditions for the cardiac structure include paravalvular leakage, ventricular septal defect, arterial venous fistula, patent foramen oval, and so on. Significantly high prevalence of cardiovascular abnormalities. In the U.S. alone, approximately 60 million individuals with 20% of the total population have structural heart defects. This represents a significant opportunity for the use of structural cardiac devices. These conditions represent a broad category of treatment, including both repair and replacement procedures, for both acquired and congenital diseases.

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/structural-heart-devices-market

Favorable reimbursements for the novel minimally invasive procedures have made procedures such as TAVR highly popular and affordable to the patients. As the global population is aging, the medical expenditure in several countries is being covered by the government and private insurers. This eases the per capita healthcare burden, therefore urging more and more patients to opt for such treatments. Furthermore, increasing awareness about the novel procedures and increasing availability of long-lasting implants drive the global market growth.

The major market players are also increasing their investments in research and development activities to enhance the effectiveness of these devices. It is expected that by 2020 some prominent and advanced pipeline products shall be commercialized. Boston Scientific Corporation, Abbott Laboratories, Medtronic, Edwards Lifesciences Corporation are some of the leading companies in this space.

Based on the type of devices, the global structural heart devices market is segmented into heart valve devices, repair devices and accessories. Among these the demand for heart valve devices is set to be the highest during the forecast period. Similarly, the replacement procedures segment in terms of procedure types is estimated to undergo the fastest market growth. Consistent growth in geriatric population, rapid adoption of transcatheter aortic valve replacement therapies, and affordable process of replacement procedures contribute to the rapid growth of this segment. Additionally, North America and Asia Pacific markets are the most prominent regions to watch during the forecast period in terms of revenue and market growth respectively. Asia Pacific region will progress at the fastest CAGR during the forecast period. Considering the competitive landscape, the global structural heart valve devices has rapidly changing dynamics. The new market entrants with promising pipeline devices are often being acquired by incumbent players with rich financial pool. The existing players are also strengthening their geographical foothold through mergers, distribution agreements and other growth strategies.

The major players operating in this market are Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic PLC, LivaNova PLC, C. R. Bard, Inc., CryoLife, Inc., Integer Holdings Corporation, Comed B.V. and JenaValve Technology, Inc. and others.

Key Market Movements:

  • Growing incidence of congenital heart defects, and high prevalence of age related structural conditions
  • Growing awareness and reducing procedure costs in Asia Pacific
  • Intensifying market entry of major market players from developed countries to emerging Asia Pacific region
  • Growing demand for minimally invasive procedures therefore paving way for transcatheter procedures

Access Free Sample Copy of Research Report: https://www.credenceresearch.com/sample-request/59510

 [Note: Our Free Complimentary Sample Report Accommodate a Brief Introduction To The Synopsis, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology are also Included]

Report Scope by Segments

By Type

 • Heart Valve Devices

 • Surgical Heart Valves

 • Transcatheter Heart Valves

 • Repair Devices

 • Occluders and Delivery Systems

 • Annuloplasty Rings

 • Others

 • Accessories

 By Procedure

 • Repair Procedures

 • Valvuloplasty

 • Transcatheter Mitral Valve Repair (TMVR)

 • Annuloplasty

 • Others

 • Replacement Procedures

 • Tissue Heart Valves

 • Mechanical Heart Valves

 • Transcatheter Aortic Valve Replacement (TAVR)

By Geography Segment

  • North America (the U.S., Rest of North America)
  • Europe (U.K., Germany, France, Rest of Europe)
  • Asia Pacific (China, Japan, India, Rest of Asia Pacific)
  • Rest of World (Middle East & Africa (MEA), Latin America)

Access Free Sample Copy of Research Report: https://www.credenceresearch.com/sample-request/59510

Leave a Reply

Your email address will not be published. Required fields are marked *